首页> 外文期刊>Virology Journal >Construction of a recombinant duck enteritis virus (DEV) expressing hemagglutinin of H5N1 avian influenza virus based on an infectious clone of DEV vaccine strain and evaluation of its efficacy in ducks and chickens
【24h】

Construction of a recombinant duck enteritis virus (DEV) expressing hemagglutinin of H5N1 avian influenza virus based on an infectious clone of DEV vaccine strain and evaluation of its efficacy in ducks and chickens

机译:基于DEV疫苗株的传染性克隆表达H5N1禽流感病毒血凝素的重组鸭肠炎病毒(DEV)的构建及其在鸭,鸡中的功效评价

获取原文
           

摘要

Background Highly pathogenic avian influenza virus (AIV) subtype H5N1 remains a threat to poultry. Duck enteritis virus (DEV)-vectored vaccines expressing AIV H5N1 hemagglutinin (HA) may be viable AIV and DEV vaccine candidates. Methods To facilitate the generation and further improvement of DEV-vectored HA(H5) vaccines, we first constructed an infectious clone of DEV Chinese vaccine strain C-KCE (DEV C-KCE ). Then, we generated a DEV-vectored HA(H5) vaccine (DEV-H5(UL55)) based on the bacterial artificial chromosome (BAC) by inserting a synthesized HA(H5) expression cassette with a pMCMV IE promoter and a consensus HA sequence into the noncoding area between UL55 and LORF11. The immunogenicity and protective efficacy of the resulting recombinant vaccine against DEV and AIV H5N1 were evaluated in both ducks and chickens. Results The successful construction of DEV BAC and DEV-H5(UL55) was verified by restriction fragment length polymorphism analysis. Recovered virus from the BAC or mutants showed similar growth kinetics to their parental viruses. The robust expression of HA in chicken embryo fibroblasts infected with the DEV-vectored vaccine was confirmed by indirect immunofluorescence and western blotting analyses. A single dose of 10 6 TCID 50 DEV-vectored vaccine provided 100?% protection against duck viral enteritis in ducks, and the hemagglutination inhibition (HI) antibody titer of AIV H5N1 with a peak of 8.2 log 2 was detected in 3-week-old layer chickens. In contrast, only very weak HI titers were observed in ducks immunized with 10 7 TCID 50 DEV-vectored vaccine. A mortality rate of 60?% (6/10) was observed in 1-week-old specific pathogen free chickens inoculated with 10 6 TCID 50 DEV-vectored vaccine. Conclusions We demonstrate the following in this study. (i) The constructed BAC is a whole genome clone of DEV C-KCE . (ii) The insertion of an HA expression cassette sequence into the noncoding area between UL55 and LORF11 of DEV C-KCE affects neither the growth kinetics of the virus nor its protection against DEV. (iii) DEV-H5(UL55) can generate a strong humoral immune response in 3-week-old chickens, despite the virulence of this virus observed in 1-week-old chickens. (iv) DEV-H5(UL55) induces a weak HI titer in ducks. An increase in the HI titers induced by DEV-vectored HA(H5) will be required prior to its wide application.
机译:背景高致病性禽流感病毒(AIV)H5N1亚型仍然对家禽构成威胁。表达AIV H5N1血凝素(HA)的鸭肠炎病毒(DEV)载体疫苗可能是可行的AIV和DEV疫苗候选人。方法为了促进DEV载体HA(H5)疫苗的产生和进一步改良,我们首先构建了DEV中国疫苗株C-KCE(DEV C-KCE )的感染性克隆。然后,我们通过插入带有pMCMV IE启动子和共有HA序列的合成HA(H5)表达盒,基于细菌人工染色体(BAC)生成了DEV载体HA(H5)疫苗(DEV-H5(UL55))。进入UL55和LORF11之间的非编码区域。在鸭和鸡中评估了所得的针对DEV和AIV H5N1的重组疫苗的免疫原性和保护效力。结果通过限制性片段长度多态性分析验证了DEV BAC和DEV-H5(UL55)的成功构建。从BAC或突变体中回收的病毒显示出与其亲本病毒相似的生长动力学。通过间接免疫荧光和western印迹分析证实了在用DEV载体疫苗感染的鸡胚成纤维细胞中HA的强表达。单剂10 6 TCID 50 DEV载体疫苗可在鸭中提供100%的抗鸭病毒性肠炎保护作用,并提供AIV H5N1的血凝抑制(HI)抗体效价在3周龄的蛋鸡中检测到8.2 log 2 的峰值。相反,在用10 7 TCID 50 DEV载体疫苗免疫的鸭子中只观察到非常弱的HI滴度。在接种10张 6 TCID 50 DEV载体疫苗的1周龄无病原体的无鸡中,死亡率达到60%(6/10)。结论我们在这项研究中证明了以下内容。 (i)构建的BAC是DEV C-KCE 的全基因组克隆。 (ii)将HA表达盒序列插入DEV C-KCE 的UL55和LORF11之间的非编码区中,既不会影响病毒的生长动力学,也不会影响其对DEV的保护。 (iii)DEV-H5(UL55)可以在3周龄的鸡中产生强烈的体液免疫反应,尽管在1周龄的鸡中观察到这种病毒的毒性。 (iv)DEV-H5(UL55)在鸭子中诱导较弱的HI滴度。由DEV载体的HA(H5)引起的HI滴度的提高将需要广泛应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号